# EPCLUSA
> **NDA214187** · New Drug Application · Sponsor: GILEAD SCIENCES INC · Approved 2021-06-10
## Drug
- **FDA Application Number:** NDA214187
- **Application type:** New Drug Application
- **Brand name:** EPCLUSA
- **Generic name:** VELPATASVIR AND SOFOSBUVIR
- **Active ingredients:** SOFOSBUVIR; VELPATASVIR
- **Dosage form:** PELLETS
- **Route:** ORAL
- **Marketing status:** Prescription
- **Sponsor:** GILEAD SCIENCES INC
- **Manufacturer:** Gilead Sciences, Inc.
- **First approval:** 2021-06-10
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=214187)
---
*MORVS · CC0 1.0*